Intellia Therapeutics Inc buy Wolfe Research
Start price
21.04.25
/
50%
€6.94
Target price
21.04.26
€18.30
Performance (%)
95.01%
Price
22.01.26
€13.53
Summary
This prediction is currently active. With a performance of 95.01% the BUY prediction by Wolfe_Research is a big success. This prediction currently runs until 21.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 32.064% | 32.064% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by Wolfe_Research for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat